Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3093-3103

  Zhang, Ying ^a,b   Ma, Cheng J ^a   Ni, Lei ^a   Zhang, Chun L ^a   Wu, Xiao Y ^a   Kumaraguru, Uday ^a   Li, Chuan F ^a   Moorman, Jonathan P ^a,c   Yao, Zhi Q ^a,b,c  

^a East Tennessee State University   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COMPLEMENT COMPONENT C1Q ANTIBODY; INTERLEUKIN 12; PROGRAMMED DEATH 1 RECEPTOR; SMALL INTERFERING RNA; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; GENE SILENCING; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INNATE IMMUNITY; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CORE;

ADULT; AGED; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CELL COMMUNICATION; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-12; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; RECEPTORS, COMPLEMENT; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTORS;

EID: 79952761607     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002006     Document Type: Article

References (45)

1. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5: 558-567.
2. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10: 439-449.
3. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191: 1499-1512.
4. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194: 1395-1406.
5. Rehermann, B., K. M. Chang, J. G. McHutchison, R. Kokka, M. Houghton, and F. V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98: 1432-1440.
6. Wedemeyer, H., X. S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169: 3447-3458. (Pubitemid 35013196)
7. Ciesek, S., H. Liermann, J. Hadem, T. Greten, H. L. Tillmann, M. Cornberg, N. Aslan, M. P. Manns, and H. Wedemeyer. 2008. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection. J. Viral Hepat. 15: 200-211. (Pubitemid 351143740)
8. Della Bella, S., A. Crosignani, A. Riva, P. Presicce, A. Benetti, R. Longhi, M. Podda, and M. L. Villa. 2007. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology 121: 283-292.
9. Mengshol, J. A., L. Golden-Mason, N. Castelblanco, K. A. Im, S. M. Dillon, C. C. Wilson, H. R. Rosen; Virahep-C Study Group. 2009. Impaired plasma-cytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 58: 964-973.
10. Saito, K., M. Ait-Goughoulte, S. M. Truscott, K. Meyer, A. Blazevic, G. Abate, R. B. Ray, D. F. Hoft, and R. Ray. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J. Virol. 82: 3320-3328. (Pubitemid 351429910)
11. Schlaak, J. F., T. Pitz, H. F. Löhr, K. H. Meyer zum Büschenfelde, and G. Gerken. 1998. Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells. J. Med. Virol. 56: 112-117.
12. Waggoner, S. N., C. H. Hall, and Y. S. Hahn. 2007. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J. Leukoc. Biol. 82: 1407-1419.
13. Wertheimer, A. M., A. Bakke, and H. R. Rosen. 2004. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40: 335-345.
14. Wertheimer, A. M., S. J. Polyak, R. Leistikow, and H. R. Rosen. 2007. Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells. Hepatology 45: 1422-1432.
15. Buisson, S., A. Benlahrech, B. Gazzard, F. Gotch, P. Kelleher, and S. Patterson. 2009. Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. J. Infect. Dis. 199: 1862-1871.
16. Hoffman, S. J., F. P. Polack, D. A. Hauer, and D. E. Griffin. 2003. Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol. 16: 369-379.
17. Renneson, J., B. Dutta, S. Goriely, B. Danis, S. Lecomte, J. F. Laes, Z. Tabi, M. Goldman, and A. Marchant. 2009. IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur. J. Immunol. 39: 2789-2799.
18. Wang, Y., G. Chaudhri, R. J. Jackson, and G. Karupiah. 2009. IL-12p40 and IL- 18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J. Immunol. 183: 3324-3331.
19. Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2: 410-416.
20. Nishimura, H., and T. Honjo. 2001. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22: 265-268. (Pubitemid 32667515)
21. Golden-Mason, L., J. Klarquist, A. S. Wahed, and H. R. Rosen. 2008. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J. Immunol. 180: 3637-3641.
22. Penna, A., M. Pilli, A. Zerbini, A. Orlandini, S. Mezzadri, L. Sacchelli, G. Missale, and C. Ferrari. 2007. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588-601. (Pubitemid 46450610)
23. Yao, S., S. Wang, Y. Zhu, L. Luo, G. Zhu, S. Flies, H. Xu, W. Ruff, M. Broadwater, I. H. Choi, et al. 2009. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113: 5811-5818.
24. Cho, H. Y., E. K. Choi, S. W. Lee, K. O. Jung, S. K. Seo, I. W. Choi, S. G. Park, I. Choi, and S. W. Lee. 2009. Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol. Lett. 127: 39-47.
25. Eyles, J. L., D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr. 2002. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J. Biol. Chem. 277: 43735-43740.
26. Said, E. A., F. P. Dupuy, L. Trautmann, Y. Zhang, Y. Shi, M. El-Far, B. J. Hill, A. Noto, P. Ancuta, Y. Peretz, et al. 2010. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16: 452-459.
27. Yao, Z. Q., E. King, D. Prayther, D. Yin, and J. Moorman. 2007. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol. 20: 276-287. (Pubitemid 47076209)
28. Moorman, J., Z. P. Dong, L. Ni, C. Zhang, T. Borthwick, and Z. Q. Yao. 2009. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection. Immunology 128: 227-235.
29. Yao, Z. Q., D. Prayther, C. Trabue, Z. P. Dong, and J. Moorman. 2008. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein. Immunology 125: 197-207.
30. Frazier, A. D., C. L. Zhang, L. Ni, C. J. Ma, Y. Zhang, X. Y. Wu, A. N. Atia, Z. Q. Yao, and J. P. Moorman. 2010. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection. Viral Immunol. 23: 487-495.
31. Yao, Z. Q., L. Ni, Y. Zhang, C. J. Ma, C. L. Zhang, Z. P. Dong, A. D. Frazier, X. Y. Wu, P. Thayer, T. Borthwick, et al. 2010. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma. Immunol. Invest. In press.
32. Ni, L., C. J. Ma, Y. Zhang, S. Nandakumar, C. L. Zhang, X. Y. Wu, T. Borthwick, A. Hamati, X. Y. Chen, U. Kumaraguru, et al. 2010. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunol. Cell Biol. In press.
33. Eisen-Vandervelde, A. L., S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn. 2004. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J. Biol. Chem. 279: 43479-43486.
34. Ma, C. J., L. Ni, Y. Zhang, C. L. Zhang, X. Y. Wu, A. N. Atia, P. Thayer, J. P. Moorman, and Z. Q. Yao. 2010. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology. In press.
35. Wenink, M. H., K. C. Santegoets, J. C. Broen, L. van Bon, S. Abdollahi-Roodsaz, C. Popa, R. Huijbens, T. Remijn, E. Lubberts, P. L. van Riel, et al. 2009. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. J. Immunol. 183: 6960-6970.
36. Bohnenkamp, H. R., K. T. Papazisis, J. M. Burchell, and J. Taylor-Papadimitriou. 2007. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell. Immunol. 247: 72-84.
37. Yao, Z. Q., A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn. 2004. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J. Virol. 78: 6409-6419.
38. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106: 1239-1249.
39. Yao, Z. Q., D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complementdependent regulatory pathway. J. Immunol. 167: 5264-5272.
40. Yao, Z. Q., S. Ray, A. Eisen-Vandervelde, S. Waggoner, and Y. S. Hahn. 2001. Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol. 14: 277-295.
41. Moorman, J. P., S. M. Fitzgerald, D. C. Prayther, S. A. Lee, D. S. Chi, and G. Krishnaswamy. 2005. Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir. Res. 6: 105.
42. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
43. Sheppard, K. A., L. J. Fitz, J. M. Lee, C. Benander, J. A. George, J. Wooters, Y. Qiu, J. M. Jussif, L. L. Carter, C. R. Wood, and D. Chaudhary. 2004. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 574: 37-41. (Pubitemid 39200891)
44. Okazaki, T., A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98: 13866-13871.
45. Kip1. Virology 314: 271-282.